Blood Serum Levels of Amino-Terminal Pro-C-Type Natriuretic Peptide in Patients with Systemic Sclerosis

REFERENCES

• Abraham, D.J., and Varga, J. (2005). Scleroderma: from cell and molecular mechanisms to disease models. Trends Immunol., 26, 587–595.
   PubMed Web of Science ®Google Scholar
• Sudoh, T., Minamino, N., Kangawa, K., and Matsuo, H. (1990). C-type natriuretic peptide (CNP): a new member of natriuretic peptide family identified in porcine brain. Biochem. Biophys. Res. Commun., 168, 863–870.
   PubMed Web of Science ®Google Scholar
• Stingo, A.J., Clavell, A.L., Heublein, D.M., Wei, C.M., Pittelkow, M.R., and Burnett, J.C.Jr. (1992). Presence of C-type natriuretic peptide in cultured human endothelial cells and plasma. Am. J. Physiol., 263, H1318–H1321.
   PubMed Web of Science ®Google Scholar
• Nakamura, M., Arakawa, N., Yoshida, H., Makita, S., and Hiramori, K. (1994). Vasodilatory effects of C-type natriuretic peptide on forearm resistance vessels are distinct from those of atrial natriuretic peptide in chronic heart failure. Circulation, 90, 1210–1214.
   PubMed Web of Science ®Google Scholar
• Prickett, T.C., Yandle, T.G., Nicholls, M.G., Espiner, E.A., and Richards, A.M. (2001). Identification of amino-terminal pro-C-type natriuretic peptide in human plasma. Biochem. Biophys. Res. Commun., 286, 513–517.
   PubMed Web of Science ®Google Scholar
• Scotland, R.S., Cohen, M., Foster, P., Lovell, M., Mathur, A., Ahluwalia, A., and Hobbs, A.J. (2005). C-type natriuretic peptide inhibits leukocyte recruitment and platelet-leukocyte interactions via suppression of P-selectin expression. Proc. Natl. Acad. Sci. USA, 102, 14452–14457.
   PubMed Web of Science ®Google Scholar
• Ahluwalia, A., Cohen, M., Scotland, R., and Hobbs, A. (2004). C-type natriuretic peptide (CNP) inhibits thrombin-induced platelet aggregation. Br. J. Pharmacol., pA2 online2, 024C.
   Google Scholar
• Kohno, M., Horio, T., Yokokawa, K., Kurihara, N., and Takeda, T. (1992). C-type natriuretic peptide inhibits thrombin- and angiotensin II-stimulated endothelin release via cyclic guanosine 3′,5′-monophosphate. Hypertension, 19, 320–325.
   PubMed Web of Science ®Google Scholar
• Masi, A.T., Rodnan, G.P., Medsger, T.A., Altman, R.D., D’Angelo, W.A., Fries, J.F., Leroy, E.C., Kirsner, A.B., MacKenzie, A.H., McShane, D.J., Myers, A.R., and Sharp, G.C. (1980). Preliminary criteria for the classification of systemic sclerosis (scleroderma). Arthr. Rheum., 23, 581–590.
   PubMed Web of Science ®Google Scholar
• LeRoy, E.C., Black, C., Fleischmajer, R., Jablonska, S., Krieg, T., Medsger, T.A.Jr, Rowell, N., and Wollheim, F. (1988). Scleroderma (systemic sclerosis): classification, subsets and pathogenesis. J. Rheumatol., 15, 202–205.
   PubMed Web of Science ®Google Scholar
• Clements, P., Lachenbruch, P., Siebold, J., White, B., Weiner, S., Martin, R., Weinstein, A., Weisman, M., Mayes, M., Collier, D., Wigley, F., Medsger, T., Steen, V., Moreland, L., Dixon, M., Massa, M., Lally, E., McCloskey, D., Varga, J., Ingenito, F., and Furst, D. (1995). Inter and intraobserver variability of total skin thickness score (modified Rodnan TSS) in systemic sclerosis. J. Rheumatol., 22, 1281–1285.
   PubMed Web of Science ®Google Scholar
• Akesson, A., Fiori, G., Krieg, T., van den Hoogen, F.H., and Seibold, J.R. (2003). Assessment of skin, joint, tendon and muscle involvement. Clin. Exp. Rheumatol., 21(3 suppl 29), S5–S8.
   PubMed Web of Science ®Google Scholar
• Kansas, G.S. (1996). Selectins and their ligands: current concepts and controversies. Blood, 88, 3259–3287.
   PubMed Web of Science ®Google Scholar
• Ateş, A., Kinikli, G., Turgay, M., and Duman, M. (2004). Serum-soluble selectin levels in patients with rheumatoid arthritis and systemic sclerosis. Scand. J. Immunol., 59, 315–320.
   PubMed Web of Science ®Google Scholar
• Qian, J.Y., Haruno, A., Asada, Y., Nishida, T., Saito, Y., Matsuda, T., and Ueno, H. (2002). Local expression of C-type natriuretic peptide suppresses inflammation, eliminates shear stress-induced thrombosis, and prevents neointima formation through enhanced nitric oxide production in rabbit injured carotid arteries. Circ. Res., 91, 1063–1069.
   PubMed Web of Science ®Google Scholar
• Ohta, S., Shimekake, Y., and Nagata, K. (1996). Molecular cloning and characterization of a transcription factor for the C-type natriuretic peptide gene promoter. Eur. J. Biochem., 242, 460–466.
   PubMedGoogle Scholar
• Mendonça, M.C., Doi, S.Q., Glerum, S., and Sellitti, D.F. (2006). Increase of C-type natriuretic peptide expression by serum and platelet-derived growth factor-BB in human aortic smooth muscle cells is dependent on protein kinase C activation. Endocrinology, 147, 4169–4178.
   PubMed Web of Science ®Google Scholar
• Ishiwata, N., Takio, K., Katayama, M., Watanabe, K., Titani, K., Ikeda, Y., and Handa, M. (1994). Alternatively spliced isoform of P-selectin is present in vivo as a soluble molecule. J. Biol. Chem., 269(38), 23708–23715.
   PubMed Web of Science ®Google Scholar
• Kamath, S., Blann, A.D., Caine, G.J., Gurney, D., Chin, B.S., and Lip, G.Y. (2002). Platelet P-selectin levels in relation to plasma soluble P-selectin and beta-thromboglobulin levels in atrial fibrillation. Stroke, 33, 1237–1242.
   PubMed Web of Science ®Google Scholar
• Yamane, K., Ihn, H., Kubo, M., Yazawa, N., Kikuchi, K., Soma, Y., and Tamaki, K. (2000). Increased serum levels of soluble vascular cell adhesion molecule 1 and E-selectin in patients with localized scleroderma. J. Am. Acad. Dermatol., 42, 64–69.
   PubMed Web of Science ®Google Scholar
• Wyble, C.W., Hynes, K.L., Kuchibhotla, J., Marcus, B.C., Hallahan, D., and Gewertz, B.L. (1997). TNF-alpha and IL-1 upregulate membrane-bound and soluble E-selectin through a common pathway. J. Surg. Res., 73, 107–112.
   PubMed Web of Science ®Google Scholar